LobbyingBluebird Bio lobbying by quarter
Bluebird Bio's latest lobbying report covers Q2 2024, at $90K. Its first report covers Q1 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Bluebird Bio
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $0 | 1 |
| Q2 2023 | $80K | 1 |
| Q3 2023 | $150K | 1 |
| Q4 2023 | $140K | 1 |
| Q1 2024 | $210K | 1 |
| Q2 2024 | $90K | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$520K · 5 reports
- Medicare and Medicaid$150K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
- Health & Human Services, Dept of (HHS)4 reports
- Centers For Medicare and Medicaid Services (CMS)2 reports
- White House Office2 reports
- Office of Management & Budget (OMB)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBluebird Bio | $670K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/11/07for Q2 2024 | In-house | $90K |
| 24/07/18for Q2 2024 | In-house | $90K |
| 24/04/19for Q1 2024 | In-house | $210K |
| 24/04/04for Q4 2023 | In-house | $140K |
| 24/04/03for Q4 2023 | In-house | $140K |
| 24/01/16for Q4 2023 | In-house | $140K |
| 23/11/09for Q3 2023 | In-house | $150K |
| 23/10/18for Q2 2023 | In-house | $80K |
| 23/10/18for Q3 2023 | In-house | $120K |
| 23/07/18for Q2 2023 | In-house | $60K |
| 23/04/18for Q1 2023 | In-house | Under $5,000 |
| 23/03/17for Q1 2023 | In-house | Under $5,000 |